6-123438944-C-T
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_006073.4(TRDN):c.991G>A(p.Glu331Lys) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.00000642 in 1,557,834 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_006073.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRDN | NM_006073.4 | c.991G>A | p.Glu331Lys | missense_variant, splice_region_variant | Exon 11 of 41 | ENST00000334268.9 | NP_006064.2 | |
TRDN | NM_001251987.2 | c.991G>A | p.Ala331Thr | missense_variant, splice_region_variant | Exon 11 of 21 | NP_001238916.1 | ||
TRDN | NM_001407315.1 | c.931G>A | p.Ala311Thr | missense_variant, splice_region_variant | Exon 10 of 20 | NP_001394244.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRDN | ENST00000334268.9 | c.991G>A | p.Glu331Lys | missense_variant, splice_region_variant | Exon 11 of 41 | 1 | NM_006073.4 | ENSP00000333984.5 | ||
TRDN | ENST00000662930.1 | c.991G>A | p.Ala331Thr | missense_variant, splice_region_variant | Exon 11 of 21 | ENSP00000499585.1 | ||||
TRDN-AS1 | ENST00000587106.6 | n.572-659C>T | intron_variant | Intron 6 of 8 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152080Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000229 AC: 4AN: 174450Hom.: 0 AF XY: 0.0000108 AC XY: 1AN XY: 92314
GnomAD4 exome AF: 0.00000356 AC: 5AN: 1405754Hom.: 0 Cov.: 29 AF XY: 0.00 AC XY: 0AN XY: 694526
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152080Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74256
ClinVar
Submissions by phenotype
Catecholaminergic polymorphic ventricular tachycardia 1;C3809536:Catecholaminergic polymorphic ventricular tachycardia 5 Uncertain:1
- -
Catecholaminergic polymorphic ventricular tachycardia 1 Uncertain:1
This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 331 of the TRDN protein (p.Glu331Lys). This variant also falls at the last nucleotide of exon 11, which is part of the consensus splice site for this exon. This variant is present in population databases (rs763851599, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with TRDN-related conditions. ClinVar contains an entry for this variant (Variation ID: 463682). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Cardiovascular phenotype Uncertain:1
The c.991G>A variant (also known as p.E331K), located in coding exon 11 of the TRDN gene, results from a G to A substitution at nucleotide position 991. The amino acid change results in glutamic acid to lysine at codon 331, an amino acid with similar properties. This change occurs in the last base pair of coding exon 11, which makes it likely to have some effect on normal mRNA splicing. However, this alteration does not impact the predominant cardiac isoform ofTRDN(NM_001256021.1; Kobayashi YM et al. J. Biol. Chem., 1999 Oct;274:28660-8). This nucleotide position is highly conserved in available vertebrate species. This amino acid position is well conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will weaken the native splice donor site. In addition, as a missense substitution this is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at